$1.50
-0.03 (-1.96%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+88.0% upside
Low Target
$1.78
Average Target
$2.82
High Target
$3.37
Current Price
$1.50
Current
$1.50
$1.50
Target
$2.82
$2.82
$1.78
$2.82 avg
$3.37
Scenario Analysis
Bear Case
$1.78
18.7%
Low target
Base Case
$2.82
+88.0%
Avg target
Bull Case
$3.37
+124.7%
High target
Risk/Reward
6.7x
Highly favorable
Price in Context
52-Week High
$3.08
-51.3% from high
52-Week Low
$0.87
+72.0% from low
Target vs 52W High
$2.82
-8.4% vs high
Next Earnings Report
Apr 6, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.26
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +19.8% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.0% |
| GILD | Strong Buy | 38 | 79% | $362.68 | +158.5% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -2.0% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.1% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -13.0% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -29.7% |